Clinical Trials at MSD France
During the past decade, MSD France conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MSD France
According to Clinical.Site data, the most researched conditions in "MSD France" are
"Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Anal Cancer" (1 trials), "Anal Carcinoma" (1 trials) and "Bile Duct Cancer" (1 trials). Many other conditions were trialed in "MSD France" in a lesser frequency.
Clinical Trials Intervention Types at MSD France
Most popular intervention types in "MSD France" are "Biological" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abiraterone acetate 1000 mg" (1 trials), "Belzutifan 120mg" (1 trials), "Carboplatin" (1 trials), "Dexamethasone 8 mg" (1 trials) and "Docetaxel 75 mg/m^2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MSD France
The vast majority of trials in "MSD France" are
2 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at MSD France
Currently, there are NaN active trials in "MSD France".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in MSD France,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MSD France, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".